The invention relates to peptide, oligopeptide or polypeptide compounds that
are capable of eliciting a protective immune response against the capsular polysaccharide
of group B Streptococcus (GBS), particularly type III GBS. Such compounds
are useful in the development of vaccines that are effective against diseases caused
by these pathogens.